These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29307500)

  • 1. Preparing the Way: Exploiting Genomic Medicine to Stop Smoking.
    Bierut LJ; Tyndale RF
    Trends Mol Med; 2018 Feb; 24(2):187-196. PubMed ID: 29307500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward the implementation of genomic applications for smoking cessation and smoking-related diseases.
    Ramsey AT; Chen LS; Hartz SM; Saccone NL; Fisher SL; Proctor EK; Bierut LJ
    Transl Behav Med; 2018 Jan; 8(1):7-17. PubMed ID: 29385591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation.
    Salloum NC; Buchalter ELF; Chanani S; Espejo G; Ismail MS; Laine RO; Nageeb M; Srivastava AB; Trapp N; Trillo L; Vance E; Wenzinger M; Hartz SM; David SP; Chen LS
    Pharmacogenomics; 2018 Jul; 19(10):861-871. PubMed ID: 29914292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in CYP2A6 and tobacco dependence throughout adolescence and in young adult smokers.
    Chenoweth MJ; Sylvestre MP; Contreras G; Novalen M; O'Loughlin J; Tyndale RF
    Drug Alcohol Depend; 2016 Jan; 158():139-46. PubMed ID: 26644138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine Dependence, Nicotine Metabolism, and the Extent of Compensation in Response to Reduced Nicotine Content Cigarettes.
    Bandiera FC; Ross KC; Taghavi S; Delucchi K; Tyndale RF; Benowitz NL
    Nicotine Tob Res; 2015 Sep; 17(9):1167-72. PubMed ID: 25555385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNPs within CHRNA5-A3-B4 and CYP2A6/B6 are associated with smoking dependence but not with tobacco dependence treatment outcomes in the Czech population.
    Hubacek JA; Pankova A; Stepankova L; Zvolska K; Adamkova V; Lanska V; Kralikova E
    Gene; 2017 Mar; 606():35-38. PubMed ID: 28069549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How.
    Chen LS; Zawertailo L; Piasecki TM; Kaprio J; Foreman M; Elliott HR; David SP; Bergen AW; Baurley JW; Tyndale RF; Baker TB; Bierut LJ; Saccone NL;
    Nicotine Tob Res; 2018 Mar; 20(4):414-424. PubMed ID: 28498934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single nucleotide polymorphisms in CHRNA5 rs16969968, CHRNA3 rs578776, and LOC123688 rs8034191 are associated with heaviness of smoking in women in Northeastern Ontario, Canada.
    Conlon MS; Bewick MA
    Nicotine Tob Res; 2011 Nov; 13(11):1076-83. PubMed ID: 21810735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association between genotype and allele frequencies of CYP2A6*12 and rs16969968 in CHRNA5 variants with smoking and body mass index in young subjects from Northeast Mexico].
    Borrego-Soto G; Costilla-Esquivel A; Padilla-Rivas GR; Cázares-Samaniego PJ; Posadas-Valay R; Velasco-Castañón JG; Mercado-Longoria R; Ortiz-López R; Rojas-Martínez A
    Rev Med Chil; 2015 Nov; 143(11):1377-85. PubMed ID: 26757861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms in CYP2A6 are associated with a risk of cigarette smoking and predispose to smoking at younger ages.
    Pérez-Rubio G; López-Flores LA; Ramírez-Venegas A; Noé-Díaz V; García-Gómez L; Ambrocio-Ortiz E; Sánchez-Romero C; Hernández-Zenteno RJ; Sansores RH; Falfán-Valencia R
    Gene; 2017 Sep; 628():205-210. PubMed ID: 28734893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung Cancer: Smoking Cessation.
    Latimer KM
    FP Essent; 2018 Jan; 464():11-16. PubMed ID: 29313652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco addiction and pharmacogenetics of nicotine metabolism.
    Swan GE; Lessov-Schlaggar CN
    J Neurogenet; 2009; 23(3):262-71. PubMed ID: 19152209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guidelines for a diagnostic and therapeutic approach to smoking addiction. A consensus report].
    Jiménez Ruiz CA; Barrueco Ferrero M; Solano Reina S; Torrecilla García M; Domínguez Grandal F; Díaz-Maroto Muñoz JL; Alonso Moreno J; La Cruz Amorós Ed Ed; Abengozar Muela R
    Arch Bronconeumol; 2003 Jan; 39(1):35-41. PubMed ID: 12550018
    [No Abstract]   [Full Text] [Related]  

  • 14. The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer.
    Spitz MR; Amos CI; Dong Q; Lin J; Wu X
    J Natl Cancer Inst; 2008 Nov; 100(21):1552-6. PubMed ID: 18957677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis.
    Chen LS; Baker T; Hung RJ; Horton A; Culverhouse R; Hartz S; Saccone N; Cheng I; Deng B; Han Y; Hansen HM; Horsman J; Kim C; Rosenberger A; Aben KK; Andrew AS; Chang SC; Saum KU; Dienemann H; Hatsukami DK; Johnson EO; Pande M; Wrensch MR; McLaughlin J; Skaug V; van der Heijden EH; Wampfler J; Wenzlaff A; Woll P; Zienolddiny S; Bickeböller H; Brenner H; Duell EJ; Haugen A; Brüske I; Kiemeney LA; Lazarus P; Le Marchand L; Liu G; Mayordomo J; Risch A; Schwartz AG; Teare MD; Wu X; Wiencke JK; Yang P; Zhang ZF; Spitz MR; Amos CI; Bierut LJ
    EBioMedicine; 2016 Sep; 11():219-226. PubMed ID: 27543155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methods and results of smoking cessation in cancer smoker's].
    Dautzenberg B
    Bull Cancer; 2012 Nov; 99(11):1007-15. PubMed ID: 23131278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Tobacco Use Phenotype Suggests the 15q25 and 19q13 Loci May be Differentially Associated With Cigarettes per Day and Tobacco-Related Problems.
    Richmond-Rakerd LS; Otto JM; Slutske WS; Ehlers CL; Wilhelmsen KC; Gizer IR
    Nicotine Tob Res; 2017 Apr; 19(4):426-434. PubMed ID: 27663783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNPs in NRXN1 and CHRNA5 are associated to smoking and regulation of GABAergic and glutamatergic pathways.
    Pérez-Rubio G; Pérez-Rodríguez ME; Fernández-López JC; Ramírez-Venegas A; García-Colunga J; Ávila-Moreno F; Camarena A; Sansores RH; Falfán-Valencia R
    Pharmacogenomics; 2016 Jul; 17(10):1145-1158. PubMed ID: 27355804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The polymorphism of the CHRNA5 gene and the strength of nicotine addiction in lung cancer and COPD patients.
    Wojas-Krawczyk K; Krawczyk P; Biernacka B; Grzybek M; Kołodziej P; Kucharczyk T; Mlak R; Milanowski J
    Eur J Cancer Prev; 2012 Mar; 21(2):111-7. PubMed ID: 21955800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Helping the "hard-core" smokers].
    Perriot J; Underner M; Peiffer G; Le Houezec J; Samalin L; Schmitt A; de Chazeron I; Doly-Kuchcik L
    Rev Mal Respir; 2012 Apr; 29(4):448-61. PubMed ID: 22542404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.